Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
SLQT.US
id: 1672

SelectQuote ($SLQT) Medicare Advantage Weakness, Rising Costs, and Misleading Growth Claims Case

The court has appointed the lead plaintiff to represent the class.
S.D. New York
Court
1:25-cv-06620
Case number
09/09/2020
Class period Start
05/01/2025
Class period End
10/10/2025
Lead Plaintiff motion deadline
  • $SLQT investors filed a claim against SelectQuote for overstating the strength of its Senior health insurance segment, misrepresenting customer retention rates, and concealing rising acquisition costs.
  • After disclosing worsening retention trends, higher costs, and slashing guidance, $SLQT dropped sharply across multiple trading sessions, including a 42% decline on May 9, 2023, and further losses following additional disappointing results.
  • $SLQT investors can join this case to be notified about potential recovery.
Case Details:

Between February 8, 2023, and August 10, 2025, SelectQuote repeatedly told investors that its Senior segment was growing profitably, driven by strong customer retention and stable acquisition costs. Executives portrayed the business as resilient, even in a challenging macroeconomic environment.

In reality, retention rates were deteriorating, marketing expenses were rising, and customer lifetime values were weakening — eroding profitability. These negative trends were not disclosed until a series of earnings reports and guidance cuts forced the truth into the open.

On May 9, 2023, SelectQuote revealed weaker-than-expected retention and raised cost concerns, causing a 42% plunge in share price. Additional declines followed in subsequent quarters as poor results persisted and the company cut guidance again.

Based on these events, $SLQT investors filed a claim against SelectQuote, alleging the company:

  • It misrepresented the performance and sustainability of its Senior segment.
  • It concealed deteriorating retention rates and rising acquisition costs.
  • It maintained inflated share prices with misleading statements about business stability.
Investors argue SelectQuote misled the market about its core business health to sustain its valuation until the truth became unavoidable.
Case Type
US Securities Class Action
Case Status
Lead Plaintiff Appointed
Alleged Offence
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Suspected Party
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
02/08/2024
Filing date
08/11/2025
Lead Plaintiff Deadline
10/10/2025

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.